Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Pan African Resources flags strong rise in earnings

(Sharecast News) - Pan African Resources reported a substantial increase in headline earnings per share and earnings per share in its first half on Friday, to between 2.14 and 2.3 cents per share, up from 1.52 cents per share for the same period in 2022. The AIM-traded firm noted that would represent an increase of between 41% and 51% year-on-year for the six months ended 31 December.

It attributed the notable improvements in earnings to a 23.9% surge in revenue to $193.9m, compared to $156.5m in 2022.

The increase was primarily due to higher gold sales volumes, which rose 8.9% to 98,458 ounces, while the average dollar-denominated gold price received during the reporting period increased 13.7% to $1,961 per ounce, up from $1,725 per ounce a year earlier.

Pan African said it released its trading update under the JSE listing requirements, which compel companies to issue a statement when there was a reasonable degree of certainty that its financial results would differ by at least 20% year-on-year.

The company added that it operates with the US dollar as its presentation currency, and the South African rand as its functional currency.

That meant that fluctuations in the USD-ZAR exchange rate significantly impacted its reported results.

During the reporting period, the average USD-ZAR exchange rate was ZAR 18.69 to the dollar, compared to 17.33 in 2022.

The closing exchange rate on 31 December was ZAR 18.30, compared to ZAR 17.01 in the prior year period.

At 1154 GMT, shares in Pan African Resources were up 3.79% at 18.6p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Entain reprices two term loans, revises interest cost outlook
(Sharecast News) - Betting and gambling giant Entain announced the successful repricing of two of its existing 'Term Loan B' loans on Monday, along with the pricing and allocation of fungible add-ons, in a bid to optimise its financial position.
Oxford Biomedica confident as it moves away from vaccine era
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core revenue for 2023, despite a 36% decrease in total revenue to £89.5m.
N Brown chairman Ron McMillan to retire
(Sharecast News) - N Brown said on Monday that chairman Ron McMillan will be retiring and stepping down from the board with effect from 30 April for personal reasons.
McCarthy out, Adshead in as Ultimate Products chair
(Sharecast News) - Ultimate Products, the parent of homeware brands including Salter and Beldray, announced a change in its leadership on Monday, with James 'Jim' McCarthy deciding to step down as non-executive chair from 31 July.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.